Samsara BioCapital, LLC - VTV THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$781,773
-35.4%
1,635,5090.0%0.24%
+12.7%
Q2 2023$1,209,950
-8.4%
1,635,5090.0%0.21%
-22.3%
Q1 2023$1,321,164
+21.9%
1,635,5090.0%0.27%
+17.2%
Q4 2022$1,084,015
-31.7%
1,635,5090.0%0.23%
-37.0%
Q3 2022$1,586,000
+29.3%
1,635,5090.0%0.37%
+13.1%
Q2 2022$1,227,000
+3.9%
1,635,5090.0%0.33%
+10.1%
Q1 2022$1,181,000
-27.4%
1,635,5090.0%0.30%
-6.0%
Q4 2021$1,627,0001,635,5090.32%
Other shareholders
VTV THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,062,000$1,880,0000.17%
GSA CAPITAL PARTNERS LLP 38,333$68,0000.01%
WEDBUSH SECURITIES INC 22,000$39,0000.00%
TWO SIGMA INVESTMENTS, LP 502,496$889,0000.00%
TWO SIGMA ADVISERS, LP 479,400$849,0000.00%
Squarepoint Ops LLC 32,917$58,0000.00%
NORTHERN TRUST CORP 136,816$243,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 8,555$15,0000.00%
Legal & General Group Plc 1,931$3,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders